Nicotinic AChR in subclassified capsaicin-sensitive and -insensitive nociceptors of the rat DRG

Journal of Neurophysiology

Volumn 93, Issue 3, 2005, Pages 1358-1371

  Rau, K K ^b   Johnson, R D ^a   Cooper, B Y ^a,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; 1,1' DILINOLEYL 3,3,3',3' TETRAMETHYLINDOCARBOCYANINE PERCHLORATE; ACETYLCHOLINE; BUNGAROTOXIN RECEPTOR; CAPSAICIN; CYTISINE; NICOTINE; NICOTINIC 4 RECEPTOR; NICOTINIC 5 RECEPTOR; NICOTINIC 6 RECEPTOR; NICOTINIC 8 RECEPTOR; NICOTINIC 9 RECEPTOR; NICOTINIC AGENT; NICOTINIC RECEPTOR; PERCHLORATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; IN VITRO STUDY; MALE; MEMBRANE CURRENT; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SKIN NERVE; SKIN SENSATION; SPINAL GANGLION;

ANIMALS; CAPSAICIN; CELL COUNT; CELLS, CULTURED; DIAGNOSTIC IMAGING; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRIC STIMULATION; GANGLIA, SPINAL; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE POTENTIALS; NEURONS; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; NOCICEPTORS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 14144254799     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00591.2004     Document Type: Article

References (92)

1. Albuquerque EX, Alkondon M, Pereira EF, Castro NG, Schrattenholz A, Barbosa CT, Bonfante-Cabarcas R, Aracava Y, Eisenberg HM, and Maelicke A. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J Pharmacol Exp Ther 280: 1117-1136, 1997.
2. Armstrong DDRML, Keele CA, and Markham JW. Observations on chemical excitants of cutaneous pain in man. J Physiol 120: 316-351, 1953.
3. Bannon AW, Decker MW, Holladay MW, Curzon P, Donnelly-Roberts D, Puttfarcken PS, Bitner RS, Diaz A, Dickenson AH, Porsolt RD, Williams M, and Arneric SP. Broad-spectrum, non-opiod analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science 279: 77-81, 1998a.
4. Bannon AW, Decker MW, Kim DJ, Campbell JE, and Arneric SP. ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic pain. Brain Res 801: 158-163, 1998b.
5. Benarroch EE and Low PA. The acetylcholine-induced flare response in evaluation of small fiber dysfunction. Ann Neurol 29: 590-595, 1991.
6. Bernardini N, Sauer SK, Haberberger R, Fischer MJ, and Reeh PW. Excitatory nicotinic and desensitizing muscarinic (M2) effects on C-nociceptors in isolated rat skin. J Neurosci 21: 3295-3302, 2001.
7. Bessou P and Perl ER. Response of cutaneous sensory units with unmyelinated fibers to noxious stimuli. J Neurophysiol 32: 1025-1043, 1969.
8. Boyd RT, Jacob MH, McEachern AE, Caron S, and Berg DK. Nicotinic acetylcholine receptor mRNA in dorsal root ganglion neurons. J Neurobiol 22: 1-14, 1991.
9. Buchli R, Ndoye A, Rodriguez JG, Zia S, Webber RJ, and Grando SA. Human skin fibroblasts express m2, m4, and m5 subtypes of muscarinic acetylcholine receptors. J Cell Biochem 74: 264-277, 1999.
10. Cardenas CG, Del Mar LP, and Scroggs RS. Variation in serotonergic inhibition of calcium channel currents in four types of rat sensory neurons differentiated by membrane properties. J Neurophysiol 74: 1870-1879, 1995.
11. 1A receptors to N- and L-type calcium channels in C-like rat dorsal root ganglion cells. J Neurophysiol 77: 3284-3296, 1997.
12. Cardenas CG, Mar LP, Vysokanov AV, Arnold PB, Cardenas LM, Surmeier DJ, and Scroggs RS. Serotonergic modulation of hyperpolarization-activated current in acutely isolated rat dorsal root ganglion neurons. J Physiol 518: 507-523, 1999.
13. Carstens E, Simons CT, Dessirier JM, Carstens MI, and Jinks SL. Role of neuronal nicotinic-acetylcholine receptors in the activation of neurons in trigeminal subnucleus caudalis by nicotine delivered to the oral mucosa. Exp Brain Res 132: 375-383, 2000.
14. Carstens E, Andersen KA, Simons CT, Carstens MI, and Jinks SL. Analgesia induced by chronic nicotine infusion in rats: differences by gender and pain. Psychopharmacology 157: 40-45, 2001.
15. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, and Johnson EC. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280: 346-356, 1997.
16. Conroy WG and Berg DK. Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J Biol Chem 270: 4424-4431, 1995.
17. Cooper BY, Johnson RD, and Rau KK. Characterization and function of TASK channels in a rat nociceptive cell. Neuroscience 129: 209-224, 2004.
18. Cooper BY, Rau K, and Johnson RD. Heat reactivity and TRP expression in capsaicin sensitive and insensitive subclassified sensory cells of the rat DRG. Soc Neurosci Abstr 381.11, 2003.
19. Cooper BY and Sessle BJ. Anatomy and physiology of the trigeminal system, In: The Headaches, edited by Oleson J, Tfelt-Hansen P, and Welch KMA. New York:Raven, 1993, p. 87-93.
20. Couturier S, Erkman L, Valera S, Rungger D, Bertrand S, Boulter J, Ballivet M, and Bertrand D. Alpha 5, alpha 3, and non-alpha 3. Three clustered avian genes encoding neuronal nicotinic acetylcholine receptor-related subunits. J Biol Chem 265: 17560-17567, 1990.
21. Cuevas J, Roth AL, and Berg DK. Two distinct classes of functional 7-containing nicotinic receptor on rat superior cervical ganglion neurons. J Physiol 525: 735-746, 2000.
22. Dani JA. Overview of nicotinic receptors and their roles in the central nervous system. Biol Psychiatry 49: 166-174, 2001.
23. Del Mar LP and Scroggs RS. Lactoseries carbohydrate antigen, Galβ1-4GlcNAc-R, is expressed by a subpopulation of capsaicin-sensitive rat sensory neurons. J Neurophysiol 76: 2192-2199, 1996.
24. Demuro A, Palma E, Eusebi F, and Miledi R. Inhibition of nicotinic acetylcholine receptors by bicuculline. Neuropharmacology 41: 854-861, 2001.
25. Dessirier JM, Chang HK, O'Mahony M, and Carstens E. Cross-desensitization of capsaicin-evoked oral irritation by high but not low concentrations of nicotine in human subjects. Neurosci Lett 290: 133-136, 2000.
26. Dessirier JM, Nguyen N, Sieffermann JM, Carstens E, and O'Mahony M. Oral irritant properties of piperine and nicotine: psychophysical evidence for asymmetrical desensitization effects. Chem Senses 24: 405-413, 1999.
27. Dessirier JM, O'Mahony M, and Carstens E. Oral irritant effects of nicotine. Psychophysical evidence for decreased sensation following repeated application of and lack of cross-desensitization to capsaicin. Ann NY Acad Sci 855: 828-830, 1998.
28. Donnelly-Roberts DL, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Anderson DJ, Campbell JE, Piattoni-Kaplan M, McKenna DG, Wasicak JT, Holladay MW, Williams M, and Arneric SP. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2- chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors. I. In vitro characterization. J Pharmacol Exp Ther 285: 777-786, 1998.
29. Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, and Heinemann S. Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79: 705-715, 1994.
30. Elgoyhen AB, Vetter DE, Katz E, Rothlin CV, Heinemann SF, and Boulter J. alpha 10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc Natl Acad Sci USA 98: 3501-3506, 2001.
31. Fjallbrant N and Iggo A. The effect of histamine, 5-hydroxytryptamine and acetylcholine on cutaneous afferent fibers. J Physiol 156: 578-590, 1961.
32. Flores CM, DeCamp RM, Kilo S, Rogers SW, and Hargreaves KM. Neuronal nicotinic receptor expression in sensory neurons of the rat trigeminal ganglion: demonstration of alpha3beta4, a novel subtype in the mammalian nervous system. J Neurosci 16: 7892-7901, 1996.
33. Flores CM, Rogers SW, Pabreza LA, Wolfe BB, and Kellar KJ. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 41: 31-37, 1992.
34. Genzen JR, Van Cleve W, and McGehee DS. Dorsal root ganglion neurons express multiple nicotinic acetylcholine receptor subtypes. J Neurophysiol 86: 1773-1782, 2001.
35. Gerzanich V, Anand R, and Lindstrom J. Homomers of alpha 8 and alpha 7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties. Mol Pharmacol 45: 212-220, 1994.
36. 2+ modulation of human neuronal alpha 3 nicotinic receptors. J Pharmacol Exp Ther 286: 311-320, 1998.
37. Grando SA, Kist DA, Qi M, and Dahl MV. Human keratinocytes synthesize, secrete, and degrade acetylcholine. J Invest Dermatol 101: 32-36, 1993.
38. Haegerstam G, Olgart L, and Edwall L. The excitatory action of acetylcholine on intradental sensory units. Acta Physiol Scand 93: 113-118, 1975.
39. Ibanez-Tallon I, Miwa JM, Wang HL, Adams NC, Crabtree GW, Sine SM, and Heintz N. Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1. Neuron 33: 893-903, 2002.
40. Jinks SL and Carstens E. Activation of spinal wide dynamic range neurons by intracutaneous microinjection of nicotine. J Neurophysiol 82: 3046-3055, 1999.
41. Keele CA and Armstrong D. Monographs of the Physiological Society [Number 12]: Substances Producing Pain and Itch. London: Arnold Publishers, 1964.
42. Kesingland AC, Gentry CT, Panesar MS, Bowes MA, Vernier JM, Cube R, Walker K, and Urban L. Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain. Pain 86: 113-118, 2000.
43. Lang PM, Burgstahler R, Sippel W, Irnich D, Schlotter-Weigel B, and Grafe P. Characterization of neuronal nicotinic acetylcholine receptors in the membrane of unmyelinated human C-fiber axons by in vitro studies. J Neurophysiol 90: 3295-3303, 2003.
44. Lips KS, Pfeil U, and Kummer W. Coexpression of alpha 9 and alpha 10 nicotinic acetylcholine receptors in rat dorsal root ganglion neurons. Neuroscience 115: 1-5, 2002.
45. Liu L, Chang GQ, Jiao YQ, and Simon SA. Neuronal nicotinic acetylcholine receptors in rat trigeminal ganglia. Brain Res 809: 238-245, 1998.
46. Liu L, Pugh W, Ma H, and Simon SA. Identification of acetylcholine receptors in adult rat trigeminal ganglion neurons. Brain Res 617: 37-42, 1993.
47. Liu L and Simon SA. Capsaicin and nicotine both activate a subset of rat trigeminal ganglion neurons. Am J Physiol Cell Physiol 270: C1807-1814, 1996.
48. Liu L, Zhu W, Zhang ZS, Yang T, Grant A, Oxford G, and Simon SA. Nicotine inhibits voltage-dependent sodium channels and sensitizes vanilloid receptors. J Neurophysiol 91: 1482-1491, 2004.
49. Luetje CW and Patrick J. Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J Neurosci 11: 837-845, 1991.
50. MacDermott AB, Role LW, and Siegelbaum SA. Presynaptic ionotropic receptors and the control of transmitter release. Annu Rev Neurosci 22: 443-485, 1999.
51. McGehee DS, and Role LW. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57: 521-546, 1995.
52. Meyer EL, Xiao Y, and Kellar KJ. Agonist regulation of rat alpha 3 beta 4 nicotinic acetylcholine receptors stably expressed in human embryonic kidney 293 cells. Mol Pharmacol 60: 568-576, 2001.
53. Meyer EM, Kuryatov A, Gerzanich V, Lindstrom J, and Papke RL. Analysis of 3-(4-hydroxy, 2-methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors. J Pharmacol Exp Ther 287: 918-925, 1998.
54. Olale F, Gerzanich V, Kuryatov A, Wang F, and Lindstrom J. Chronic nicotine exposure differentially affects the function of human alpha3, alpha4, and alpha7 neuronal nicotinic receptor subtypes. J Pharmacol Exp Ther 283: 675-683, 1997.
55. Papadopolou S, Hartmann P, Lips KS, Kummer W, and Haberberger RV. Nicotinic receptor mediated Stimulation of NO-generation in neurons of rat thoracic dorsal root ganglia. Neurosci Lett 361: 32-35, 2004.
56. Papke RL. The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity. Prog Neurobiol 41: 509-531, 1993.
57. Papke RL and Heinemann SF. Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit. Mol Pharmacol 45: 142-149, 1994.
58. Papke RL, Meyer EM, Lavieri S, Bollampally SR, Papke TA, Horenstein NA, Itoh Y, and Porter Papke JK. Effects at a distance in alpha 7 nAChR selective agonists: benzylidene substitutions that regulate potency and efficacy. Neuropharmacol 46: 1023-1038, 2004.
59. Papke RL, Webster JC, Lippiello PM, Bencherif M, and Francis MM. The activation and inhibition of human nicotinic acetylcholine receptor by RJR-2403 indicate a selectivity for the alpha4beta2 receptor subtype. J Neurochem 75: 204-216, 2000.
60. Parkhouse N and Le Quesne PM. Quantitative objective assessment of peripheral nociceptive C fiber function. J Neurol Neurosurg Psychiatry 51: 28-34, 1988.
61. Parnavelas JG, Kelly W, and Burnstock G. Ultrastructural localization of choline acetyltransferase in vascular endothelial cells in rat brain. Nature 316: 724-725, 1985.
62. Petruska JC, Cooper BY, Gu JG, Rau KK, and Johnson RD. Distribution of P2X1, P2X2, and P2X3 receptor subunits in rat primary afferents: relation to population markers and specific cell types. J Chem Neuroanat 20: 141-162, 2000a.
63. Petruska JC, Napaporn J, Johnson RD, Gu JG, and Cooper BY. Subclassified acutely dissociated cells of rat DRG: histochemistry and patterns of capsaicin-, proton-, and ATP-activated currents. J Neurophysiol 84: 2365-2379, 2000b.
64. Petruska JC, Napaporn J, Johnson RD, and Cooper BY. Chemical responsiveness and histochemical phenotype of electrophysiologically classified cells of the adult rat dorsal root ganglion. Neuroscience 115: 15-30, 2002.
65. Ramirez-Lattore J Yu, CR, Qu X, Perin F, Karlin A, and Role L. Functional contributions of α5 subunit to neuronal acetylcholine receptor channels (Letter). Nature 380, 347-351, 1996.
66. Rau KK, Cooper BY, and Johnson RD. Expression of TASK-1, TASK-2 and TASK-3 in subclassified sensory cells of the rat DRG. Soc Neurosci Abstr 861.5, 2004.
67. Rueter LE, Kohlhaas KL, Curzon P, Surowy CS, and Meyer MD. Peripheral and central sites of action for A-85380 in the spinal nerve ligation model of neuropathic pain. Pain 103: 269-276, 2003.
68. Ringkamp M, Peng YB, Wu G, Hartke TV, Campbell JN, and Meyer RA. Capsaicin responses in heat-sensitive and heat-insensitive A-fiber nociceptors. J Neurosci 21: 4460-4468, 2001.
69. Rothlin CV, Katz E, Verbitsky M, and Elgoyhen AB. The alpha9 nicotinic acetylcholine receptor shares pharmacological properties with type A gamma-aminobutyric acid, glycine, and type 3 serotonin receptors. Mol Pharmacol 55: 248-254, 1999.
70. Schmelz M, Schmidt R, Weidner C, Billiges M, Torebjork HE, and Handwerker HO. Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol 89: 2441-2448, 2003.
71. Seguela P, Wadiche J, Dineley-Miller K, Dani JA, and Patrick JW. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J Neurosci 13: 596-604, 1993.
72. Snider WD and McMahon SB. Tackling pain at the source: new ideas about nociceptors. Neuron 20: 629-632, 1998.
73. Stauderman KA, Mahaffy LS, Akong M, Velicelebi G, Chavez-Noriega LE, Crona JH, Johnson EC, Elliott KJ, Gillespie A, Reid RT, Adams P, Harpold MM, and Corey-Naeve J. Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations alpha2beta4, alpha3beta4 and alpha4beta4 stably expressed in HEK293 cells. J Pharmacol Exp Ther 284: 777-789, 1998.
74. Steen KH and Reeh PW. Actions of cholinergic agonists and antagonists on sensory nerve endings in rat skin, in vitro. J Neurophysiol 70: 397-405, 1993.
75. Stetzer E, Ebbinghaus U, Storch A, Poteur L, Schrattenholz A, Kramer G, Methfessel C, and Maelicke A. Stable expression in HEK-293 cells of the rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor. FEBS Lett 397: 39-44, 1996.
76. Sucher NJ, Cheng TP, and Lipton SA. Neural nicotinic acetylcholine responses in sensory neurons from postnatal rat. Brain Res 533: 248-254, 1990.
77. Sudo S, Sudo M, Simons CT, Dessirier JM, and Carstens E. Sensitization of trigeminal caudalis neuronal responses to intraoral acid and salt stimuli and desensitization by nicotine. Pain 98: 277-286, 2002.
78. Tanelian DL. Cholinergic activation of a population of corneal afferent nerves. Exp Brain Res 86: 414-420, 1991.
79. Treede RD, Meyer RA, Raja SN, and Campbell JN. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 38: 397-421, 1992.
80. Verbitsky M, Rothlin CV, Katz E, and Elgoyhen AB. Mixed nicotinic-muscarinic properties of the alpha9 nicotinic cholinergic receptor. Neuropharmacology 39: 2515-2524, 2000.
81. Vincler M and Eisenach JC. Plasticity of spinal nicotinic acetylcholine receptors following spinal nerve ligation. Neurosci Res 48: 139-145, 2004.
82. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, and Swanson LW. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 284: 314-335, 1989.
83. Walmsley D and Wiles PG. Assessment of the neurogenic flare response as a measure of nociceptor C fiber function. J Med Eng Technol 14: 194-196, 1990.
84. Wang F, Gerzanich V, Wells GB, Anand R, Peng X, Keyser K, and Lindstrom J. Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits. J Biol Chem 271: 17656-17665, 1996.
85. Wessler I, Kirkpatrick CJ, and Racke K. The cholinergic "pitfall": acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol 26: 198-205, 1999.
86. Wessler I, Kirkpatrick CJ, and Racke K. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther 77: 59-79, 1998.
87. Wilson A and Stoner HB. The effect of injection of acetylcholine into brachial artery of normal subjects and patients with myasthenia gravis. Q J Med 16: 237-243, 1947.
88. Wong ET, Holstad SG, Mennerick SJ, Hong SE, Zorumski CF, and Isenberg KE. Pharmacological and physiological properties of a putative ganglionic nicotinic receptor, alpha 3 beta 4, expressed in transfected eucaryotic cells. Brain Res Mol Brain Res 28: 101-109, 1995.
89. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci 20: 92-98, 1997.
90. Yu CR and Role LW. Functional contribution of the alpha5 subunit to neuronal nicotinic channels expressed by chick sympathetic ganglion neurons. J Physiol 509: 667-681, 1998.
91. Zia S, Ndoye A, Lee TX, Webber RJ, and Grando SA. Receptor-mediated inhibition of keratinocyte migration by nicotine involves modulations of calcium influx and intracellular concentration. J Pharmacol Exp Ther 293: 973-981, 2000.
92. Zwart R and Vijverberg HP. Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects. Mol Pharmacol 52: 886-895, 1997.